Home
About
Overview
Sharing Data
ORCID
Help
History (119)
MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.
Comparative mutational profiling in the assessment of lung lesions: should it be the standard of care?
Association of Body Mass Index With Outcomes in Patients Undergoing Percutaneous Left Atrial Appendage Closure With the Watchman Device.
Mitophagy and the mitochondrial unfolded protein response in neurodegeneration and bacterial infection.
An in vivo platform for tumor biomarker assessment.
See All 119 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
An in vivo platform for tumor biomarker assessment.
Servais EL, Suzuki K, Colovos C, Rodriguez L, Sima C, Fleisher M, Rusch VW, Sadelain M, Adusumilli PS. An in vivo platform for tumor biomarker assessment. PLoS One. 2011; 6(10):e26722.
View in:
PubMed
subject areas
Animals
Biomarkers, Tumor
Diagnostic Imaging
GPI-Linked Proteins
Mesothelioma
Methods
Mice
Models, Animal
Osteopontin
Pleural Neoplasms
authors with profiles
Elliot L Servais MD